Nabriva Therapeutics plc (NBRVF.US) Latest Stock News - Major News Analysis - Longbridge

Quote List Quote List

Event Tracking

Nov11

Nabriva Therapeutics plc released FY2022 Q3 earnings on November 10 After-Market EST, actual revenue $9.153M (forecast $10.68M), actual EPS -$4.2133

00:00

Schedules & Filings

Schedules

Filings

Oct19

Earning Release(EST)

FY2023 Q2 Earning Release (USD) Revenue 2.243 M, Net Income -12.06 M, EPS -3.7334

May22

Earning Release(EST)

FY2023 Q1 Earning Release (USD) Revenue 7.59 M, Net Income -8.7 M, EPS -2.7174

Apr17

Earning Release(EST)

FY2022 Q4 Earning Release (USD) Revenue 10.57 M, Net Income -22.78 M, EPS -7.3249

View More

Stock List

Top Gainers

Top Decliners

China Concepts

Symbol

Price

%Chg

Change

View More